David Roshan
Overview
Explore the profile of David Roshan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
96
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wagner K, Abraham E, Tran B, Roshan D, Wykes J, Campbell P, et al.
ANZ J Surg
. 2020 Aug;
90(9):1727-1732.
PMID: 32761711
Background: Lymphovascular invasion (LVI) is an established adverse prognostic factor in many cancers, however, there are few studies assessing its significance in papillary thyroid carcinoma (PTC). We aimed to determine...
2.
Abraham E, Roshan D, Tran B, Wykes J, Campbell P, Ebrahimi A
J Surg Oncol
. 2019 Aug;
120(6):1016-1022.
PMID: 31452204
Background And Objectives: In papillary thyroid cancer (PTC), the adverse prognostic impact of extrathyroidal extension (macro-ETE) invading the subcutaneous soft tissues, larynx, trachea, esophagus, or recurrent laryngeal nerve (T4a disease)...
3.
Sood A, Wykes J, Roshan D, Wang L, McGuinness J, Forstner D, et al.
ANZ J Surg
. 2019 Apr;
89(7-8):863-867.
PMID: 30974495
Background: Existing prognostic systems for metastatic cutaneous squamous cell carcinoma of the head and neck (cSCCHN) do not discriminate between the number of involved nodes beyond single versus multiple. This...
4.
Abraham E, Roshan D, Tran B, Graham S, Lehane C, Wykes J, et al.
Head Neck
. 2019 Mar;
41(8):2549-2554.
PMID: 30860642
Background: Although microscopic positive margins appear to have no independent prognostic impact in papillary thyroid cancer (PTC), this may not be the case in pT4a tumors. Methods: Retrospective analysis of...
5.
Sood A, Wykes J, Roshan D, Wang L, McGuinness J, Fowler A, et al.
Head Neck
. 2019 Jan;
41(6):1591-1596.
PMID: 30659690
Background: The 8th edition AJCC staging of cutaneous squamous cell carcinoma of the head and neck (cSCCHN) incorporated extranodal extension (ENE) for the first time. This study compared the prognostic...
6.
Abraham E, Tran B, Roshan D, Graham S, Lehane C, Wykes J, et al.
ANZ J Surg
. 2018 Nov;
88(11):1212-1213.
PMID: 30387288
No abstract available.
7.
Tran B, Roshan D, Abraham E, Wang L, Garibotto N, Wykes J, et al.
Thyroid
. 2018 Jun;
28(8):991-996.
PMID: 29921174
Background: Although the importance of tumor size in papillary thyroid cancer (PTC) is well established, there is no research investigating whether age modifies the impact of tumor size, and there...
8.
Abraham E, Tran B, Roshan D, Graham S, Lehane C, Wykes J, et al.
ANZ J Surg
. 2018 Apr;
88(11):1193-1197.
PMID: 29701284
Background: The prognostic significance of microscopic positive margins in papillary thyroid carcinoma (PTC) remains unclear. The aim of this study was to determine if microscopic positive margins are associated with...
9.
Tran B, Roshan D, Abraham E, Wang L, Garibotto N, Wykes J, et al.
J Clin Endocrinol Metab
. 2018 Apr;
103(6):2199-2206.
PMID: 29672723
Background: The American Joint Committee on Cancer (AJCC) removed microscopic extrathyroidal extension (ETE) from the 8th edition T staging for papillary thyroid cancer (PTC) based on increasing evidence that it...
10.
Jabbour J, Milross C, Sundaresan P, Ebrahimi A, Shepherd H, Dhillon H, et al.
Cancer
. 2017 Jan;
123(11):1949-1957.
PMID: 28081302
Background: Head and neck cancer (HNC) encompasses a diverse group of tumors, and thus providing appropriate and tailored information to patients before, during, and after treatment is a challenge. The...